168 related articles for article (PubMed ID: 26366416)
1. Lysophosphatidic Acid Inhibits Apoptosis Induced by Cisplatin in Cervical Cancer Cells.
Sui Y; Yang Y; Wang J; Li Y; Ma H; Cai H; Liu X; Zhang Y; Wang S; Li Z; Zhang X; Wang J; Liu R; Yan Y; Xue C; Shi X; Tan L; Ren J
Biomed Res Int; 2015; 2015():598386. PubMed ID: 26366416
[TBL] [Abstract][Full Text] [Related]
2. Lysophosphatidic acid inhibits anti-Fas-mediated apoptosis enhanced by actin depolymerization in epithelial ovarian cancer.
Meng Y; Kang S; Fishman DA
FEBS Lett; 2005 Feb; 579(5):1311-9. PubMed ID: 15710431
[TBL] [Abstract][Full Text] [Related]
3. [Influce of lysophosphatidic acid on proliferation, adhesion, migration and apoptosis of cervical cancer HeLa cells].
Sun H; Zhu Q; Ren J; Wu L; Kong FZ; Li G; Hu HF
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 Aug; 25(8):702-5. PubMed ID: 19664393
[TBL] [Abstract][Full Text] [Related]
4. Serum bioactive lysophospholipids prevent TRAIL-induced apoptosis via PI3K/Akt-dependent cFLIP expression and Bad phosphorylation.
Kang YC; Kim KM; Lee KS; Namkoong S; Lee SJ; Han JA; Jeoung D; Ha KS; Kwon YG; Kim YM
Cell Death Differ; 2004 Dec; 11(12):1287-98. PubMed ID: 15297884
[TBL] [Abstract][Full Text] [Related]
5. Sensitivity to Fas-mediated apoptosis in high-risk HPV-positive human cervical cancer cells: relationship with Fas, caspase-8, and Bid.
Hougardy BM; van der Zee AG; van den Heuvel FA; Timmer T; de Vries EG; de Jong S
Gynecol Oncol; 2005 May; 97(2):353-64. PubMed ID: 15863130
[TBL] [Abstract][Full Text] [Related]
6. Lysophosphatidic acid prevents apoptosis of Caco-2 colon cancer cells via activation of mitogen-activated protein kinase and phosphorylation of Bad.
Rusovici R; Ghaleb A; Shim H; Yang VW; Yun CC
Biochim Biophys Acta; 2007 Aug; 1770(8):1194-203. PubMed ID: 17544220
[TBL] [Abstract][Full Text] [Related]
7. alpha-TEA inhibits survival and enhances death pathways in cisplatin sensitive and resistant human ovarian cancer cells.
Yu W; Shun MC; Anderson K; Chen H; Sanders BG; Kline K
Apoptosis; 2006 Oct; 11(10):1813-23. PubMed ID: 16850165
[TBL] [Abstract][Full Text] [Related]
8. Translocation of Fas by LPA prevents ovarian cancer cells from anti-Fas-induced apoptosis.
Meng Y; Kang S; So J; Reierstad S; Fishman DA
Gynecol Oncol; 2005 Feb; 96(2):462-9. PubMed ID: 15661236
[TBL] [Abstract][Full Text] [Related]
9. Human papilloma virus 16 E6 RNA interference enhances cisplatin and death receptor-mediated apoptosis in human cervical carcinoma cells.
Tan S; Hougardy BM; Meersma GJ; Schaap B; de Vries EG; van der Zee AG; de Jong S
Mol Pharmacol; 2012 May; 81(5):701-9. PubMed ID: 22328720
[TBL] [Abstract][Full Text] [Related]
10. Lysophosphatidic acid protects mesenchymal stem cells against hypoxia and serum deprivation-induced apoptosis.
Chen J; Baydoun AR; Xu R; Deng L; Liu X; Zhu W; Shi L; Cong X; Hu S; Chen X
Stem Cells; 2008 Jan; 26(1):135-45. PubMed ID: 17932426
[TBL] [Abstract][Full Text] [Related]
11. Enhancement of chemotherapeutic agent-induced apoptosis by inhibition of NF-kappaB using ursolic acid.
Li Y; Xing D; Chen Q; Chen WR
Int J Cancer; 2010 Jul; 127(2):462-73. PubMed ID: 19908232
[TBL] [Abstract][Full Text] [Related]
12. Lifeguard inhibition of Fas-mediated apoptosis: A possible mechanism for explaining the cisplatin resistance of triple-negative breast cancer cells.
Radin D; Lippa A; Patel P; Leonardi D
Biomed Pharmacother; 2016 Feb; 77():161-6. PubMed ID: 26796280
[TBL] [Abstract][Full Text] [Related]
13. miR‑519d‑3p/HIF‑2α axis increases the chemosensitivity of human cervical cancer cells to cisplatin via inactivation of PI3K/AKT signaling.
Jiang L; Shi S; Li F; Shi Q; Zhong T; Zhang H; Xia Y
Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33760204
[TBL] [Abstract][Full Text] [Related]
14. PDCD6 additively cooperates with anti-cancer drugs through activation of NF-κB pathways.
Park SH; Lee JH; Lee GB; Byun HJ; Kim BR; Park CY; Kim HB; Rho SB
Cell Signal; 2012 Mar; 24(3):726-33. PubMed ID: 22142513
[TBL] [Abstract][Full Text] [Related]
15. Rituximab modifies the cisplatin-mitochondrial signaling pathway, resulting in apoptosis in cisplatin-resistant non-Hodgkin's lymphoma.
Alas S; Ng CP; Bonavida B
Clin Cancer Res; 2002 Mar; 8(3):836-45. PubMed ID: 11895917
[TBL] [Abstract][Full Text] [Related]
16. Ionizing radiation utilizes c-Jun N-terminal kinase for amplification of mitochondrial apoptotic cell death in human cervical cancer cells.
Kim MJ; Lee KH; Lee SJ
FEBS J; 2008 May; 275(9):2096-108. PubMed ID: 18373696
[TBL] [Abstract][Full Text] [Related]
17. XIAP regulates Akt activity and caspase-3-dependent cleavage during cisplatin-induced apoptosis in human ovarian epithelial cancer cells.
Asselin E; Mills GB; Tsang BK
Cancer Res; 2001 Mar; 61(5):1862-8. PubMed ID: 11280739
[TBL] [Abstract][Full Text] [Related]
18. Up-regulation of interleukin-6 in human ovarian cancer cell via a Gi/PI3K-Akt/NF-kappaB pathway by lysophosphatidic acid, an ovarian cancer-activating factor.
Chou CH; Wei LH; Kuo ML; Huang YJ; Lai KP; Chen CA; Hsieh CY
Carcinogenesis; 2005 Jan; 26(1):45-52. PubMed ID: 15471896
[TBL] [Abstract][Full Text] [Related]
19. Inhibiting the cytoplasmic location of HMGB1 reverses cisplatin resistance in human cervical cancer cells.
Xia J; Yu X; Song X; Li G; Mao X; Zhang Y
Mol Med Rep; 2017 Jan; 15(1):488-494. PubMed ID: 27959427
[TBL] [Abstract][Full Text] [Related]
20. Propofol enhances the cisplatin-induced apoptosis on cervical cancer cells via EGFR/JAK2/STAT3 pathway.
Li H; Lu Y; Pang Y; Li M; Cheng X; Chen J
Biomed Pharmacother; 2017 Feb; 86():324-333. PubMed ID: 28011380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
